Patients with advanced kidney cancer who received an experimental vaccine after their tumors were removed were still ...

A phase Ib study of immunotherapy with ex-vivo pre-activated and expanded CBNK cells in combination with cetuximab, in patients with colorectal cancer (CRC) with minimal residual disease (MRD): Final ...

High disease control rate and strong interim safety results observed in pancreatic cancer patients across three trials exploring the use of ...

The company announced interim data showing strong systemic responses in its safety and efficacy study combining Alpha DaRT treatment with ...

Cutaneous metastases from rectal adenocarcinoma can reach the skin via four main routes (Braverman, 1981; Resnik, 1999). Most commonly, tumor cells spread to the skin via lymphatic and/or ...

Pfizer Inc. (NYSE: PFE) today announced positive topline results from the progression-free survival (PFS) analysis of the Phase 3 BREAKWATER study of ...

A "watch and wait" strategy after total neoadjuvant therapy showed similar outcomes and safety to total mesorectal in stage ...

Read the full guideline, “Systemic Therapy for Stage I-III Anal Squamous Cell Carcinoma: ASCO Guideline” at ... based guideline from ASCO on the management of locally advanced rectal cancer. They ...

Signet ring cell carcinoma represents an uncommon histological type for rectal cancer with less than 1% of all rectal neoplasms. It usually behaves aggressively and has an inferior prognosis. We ...

Explore the role of the extracellular matrix (ECM) in prostate cancer progression and discover natural therapies, including ...